| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004691A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004690A2 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/16/2003 | WO2003004689A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004685A2 Soluble steroidal peptides for nucleic acid delivery |
| 01/16/2003 | WO2003004684A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004682A2 Nucleic acid regulatory sequences and uses thereof |
| 01/16/2003 | WO2003004681A2 Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon |
| 01/16/2003 | WO2003004679A2 Enoyl-acp reductases |
| 01/16/2003 | WO2003004678A2 Novel receptors |
| 01/16/2003 | WO2003004675A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004674A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004673A1 Process for the fermentative preparation of d-pantothenic acid and/or salts thereof |
| 01/16/2003 | WO2003004672A1 Process for the fermentative preparation of d-pantothenic acid and/or salts thereof |
| 01/16/2003 | WO2003004671A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004670A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression |
| 01/16/2003 | WO2003004669A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression |
| 01/16/2003 | WO2003004665A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004664A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression |
| 01/16/2003 | WO2003004663A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004662A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004661A2 Adenovital vectors with cell type specificity for mesenchymal cells |
| 01/16/2003 | WO2003004660A1 Methods of administering vectors to synaptically connected neurons |
| 01/16/2003 | WO2003004659A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/16/2003 | WO2003004658A2 Gene expression in plastids based on replicating vectors |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004656A1 Method for obtaining cells with new properties |
| 01/16/2003 | WO2003004655A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | WO2003004654A1 Process for producing nicotinamide adenine dinucleotide phosphate (nadp) |
| 01/16/2003 | WO2003004653A1 Method of modifying enzyme and oxidoreductase variant |
| 01/16/2003 | WO2003004652A2 Use of a tyrosine recombinase for genetic engineering |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004649A1 Method of interfering with a virus infection in plants |
| 01/16/2003 | WO2003004648A1 Anti_human ovarian cancer -anti_cd3 bispecific antibody |
| 01/16/2003 | WO2003004647A1 Genetically modified ecarin and process for producing the same |
| 01/16/2003 | WO2003004646A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/16/2003 | WO2003004644A1 Delivery of dsrna to arthropods |
| 01/16/2003 | WO2003004643A2 Reversed mammalian protein-protein interaction trap |
| 01/16/2003 | WO2003004642A1 Method of amplifying noncyclic nucleic acid fragment |
| 01/16/2003 | WO2003004639A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
| 01/16/2003 | WO2003004637A1 Utilization of histamine receptor h3 gene participating in body weight or food intake control |
| 01/16/2003 | WO2003004636A2 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | WO2003004635A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof |
| 01/16/2003 | WO2003004634A2 Carboxypeptidase of cocoa |
| 01/16/2003 | WO2003004631A2 USE OF INHIBITORS OF EXPRESSION OR ACTIVITY OF p8/com1 FOR TREATING TUMORS. |
| 01/16/2003 | WO2003004630A2 Method for determining the genetic predisposition of a mammal for its milk fat content and/or for its intramuscular fat content |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004626A1 A bioprocess for the generation of cells derived from spheroid-forming cells |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004619A2 Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004611A2 Human olfactory nucleotide-gated ion channels |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004606A2 Antisense oligonucleotides and related methods for regulating cell death |
| 01/16/2003 | WO2003004605A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004603A2 Methods of modulating pharmacokinetics of oligonucleotides |
| 01/16/2003 | WO2003004602A2 Nuclease resistant chimeric oligonucleotides |
| 01/16/2003 | WO2003004600A2 Improvement of viral uptake into cells and tissues |
| 01/16/2003 | WO2003004599A2 Methods of making and using expression constructs for the expression of recombinant proteins |
| 01/16/2003 | WO2003004598A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/16/2003 | WO2003004595A2 Materials and methods relating to protein and nucleic acid evolution |
| 01/16/2003 | WO2003004569A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 01/16/2003 | WO2003004533A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 01/16/2003 | WO2003004531A2 Regulation of human somatostatin receptor-like protein |
| 01/16/2003 | WO2003004530A1 Regulation of human somatostatin receptor-like protein |
| 01/16/2003 | WO2003004526A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 01/16/2003 | WO2003004525A2 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 01/16/2003 | WO2003004522A1 Method for the reversible in vivo heat inactivation of proteins with biological activity |
| 01/16/2003 | WO2003004521A2 Nucleotide sequence and method for increasing the resistance to disease in plants |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004517A2 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | WO2003004513A1 Antisense modulation of hkr1 expression |
| 01/16/2003 | WO2003004511A2 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 01/16/2003 | WO2003004149A1 Novel separation agent for separating optical isomer and method for preparation thereof |
| 01/16/2003 | WO2003004088A2 Method of administration of a gene of interest to the heart and vasculature |
| 01/16/2003 | WO2003004066A1 Gene therapeutics |
| 01/16/2003 | WO2003004065A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 01/16/2003 | WO2003004063A1 Genetically engineered therapy method for treating gnrh receptor-positive carcinoma by gnrh-induced tumor cell-specific activation of a therapeutic gene, corresponding nucleic acid constructs and vectors |
| 01/16/2003 | WO2003004055A2 Nucleic acid adjuvants |
| 01/16/2003 | WO2003004050A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | WO2003004047A1 Cell death inducers for mast cells |
| 01/16/2003 | WO2003004037A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2003003824A1 Potential-dependent ca2+ channel a1b knockout non-human animal |
| 01/16/2003 | WO2003003816A2 Methods for enhancing segregation of transgenes in plants and compositions thereof |
| 01/16/2003 | WO2003003810A2 Methods for detection and quantification of analytes in complex mixtures |
| 01/16/2003 | WO2002094194A3 Compositions and methods for inhibiting metastasis |
| 01/16/2003 | WO2002088178A3 Antigens of group b streptococcus and corresponding dna fragments |
| 01/16/2003 | WO2002081679A3 Controlling dna packaging |
| 01/16/2003 | WO2002077026A3 Gene involved in v(d)j recombination and/or dna repair |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002070690A3 Abca5 transporter and uses thereof |
| 01/16/2003 | WO2002062379A3 Clostridium difficile vaccine |
| 01/16/2003 | WO2002061097A8 Cloning vectors and vector components |